[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335393-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335393-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-mrna-coding-genes-in-prostate-cancer-using-crisprcas9-technology-special-focus-on-androgen-receptor-signaling","Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology - special focus on androgen receptor signaling","","Prostate cancer is highlighted as a prevalent malignancy in men, and the review analyzes how CRISPR/Cas9 can intervene in key prostate cancer signaling networks. It summarizes recent progress in using CRISPR/Cas9 to modify prostate cancer cell phenotypes, with particular emphasis on androgen receptor signaling pathways. The review reports successful targeting of multiple genes, including evidence from animal models for reducing tumor burden. It further notes that androgen receptor-related genes influence growth of castration-resistant prostate cancer and that PI3K/AKT/mTOR signaling and immune response genes have also been effectively modulated, supporting future clinical translation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-mrna-coding-genes-in-prostate-cancer-using-crisprcas9-technology-special-focus-on-androgen-receptor-signaling/335393/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-mrna-coding-genes-in-prostate-cancer-using-crisprcas9-technology-special-focus-on-androgen-receptor-signaling/335393.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this review?","Question",{"text":63,"@type":64},"It summarizes recent advances in applying CRISPR/Cas9 to modify prostate cancer–related phenotypes, with a special focus on androgen receptor signaling pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which signaling area receives special emphasis?",{"text":68,"@type":64},"Androgen receptor signaling, including how targeted gene modulation affects the growth of castration-resistant prostate cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"What other gene targets are mentioned besides androgen receptor signaling?",{"text":72,"@type":64},"The review also highlights targets related to PI3K/AKT/mTOR signaling and immune response pathways that have been successfully modulated using CRISPR/Cas9.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335393,1790016149,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Tabibian et al. Cell Communication and Signaling (2024) 22:504  \n[https://doi.org/10.1186/s12964-024-01833-1](https://doi.org/10.1186/s12964-024-01833-1)  \nCell Communication and Signaling  \nREVIEW Open Access  \nTargeting mRNA-coding genes in prostate  cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signaling  \nMobina Tabibian3†, Fahimeh Salasar Moghaddam 1†, Elahe Motevaseli2* and Soudeh Ghafouri-Fard 1*  \nAbstract  \nBackground Prostate cancer is among prevalent cancers in men. Numerous strategies have been proposed to intervene with the important prostate cancer-related signaling pathways. Among the most promising strategies is CRISPR/Cas9 strategy. This strategy has been used to modify expression of a number of genes in prostate cancer cells. Aims This review summarizes the most recent progresses in the application of CRISPR/Cas9 strategy in modification of prostate cancer-related phenotypes with an especial focus on pathways related to androgen receptor signaling. Conclusion CRISPR/Cas9 technology has successfully targeted several genes in the prostate cancer cells. Moreover, the efficiency of this technique in reducing tumor burden has been tested in animal models of prostate cancer. Most of targeted genes have been related with the androgen receptor signaling. Targeted modulation of these genes have affected growth of castration-resistant prostate cancer. PI3K/AKT/mTOR signaling and immune response-related genes have been other targets that have been successfully modulated by CRISPR/Cas9 technology in prostate cancer. Based on the rapid translation of this technology into the clinical application, it is anticipated that novel treatments based on this technique change the outcome of this malignancy in future.  \nKeywords Prostate cancer, Androgen receptor, CRISPR/Cas9  \n†MobinaTabibian and Fahimeh Salasar Moghaddam contributed equally to this work.  \n*Correspondence:  \nElahe Motevaseli[e_motevaseli@tums.ac.ir](e_motevaseli@tums.ac.ir)[ ](e_motevaseli@tums.ac.ir)Soudeh Ghafouri-Fard[s.ghafourifard@sbmu.ac.ir](s.ghafourifard@sbmu.ac.ir)  \n1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n2Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran 3Department of Cellular and Molecular Biology, Faculty of Life Sciences and Biotechnologies, Shahid Beheshti University, Tehran, Iran  \nIntroduction  \nThe CRISPR system is an innovative genome editing apparatus that is able to reform the outline of cancer research and treatment. Its capacity to accurately target and edit certain genetic mutations that initiate the growth and spread of cancer cells has offered new prospects for the design of more effective and personalized options for treatment of cancer. Historically, it was discovered in the prokaryotes. In 1987, Ishino et al. made a groundbreaking discovery that revolutionized the medical and biological sciences: the recognition of the prokaryotic immune response mechanism CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). While conducting their research on the iap enzyme and its role in converting the alkaline phosphatase isozymes in the periplasm  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If materia","cbCailPqyvE9a2Mb","https://ap.wps.com/l/cbCailPqyvE9a2Mb","pdf",1813660,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main purpose of this review?\",\"answer\":\"It summarizes recent advances in applying CRISPR/Cas9 to modify prostate cancer–related phenotypes, with a special focus on androgen receptor signaling pathways.\"},{\"question\":\"Which signaling area receives special emphasis?\",\"answer\":\"Androgen receptor signaling, including how targeted gene modulation affects the growth of castration-resistant prostate cancer.\"},{\"question\":\"What other gene targets are mentioned besides androgen receptor signaling?\",\"answer\":\"The review also highlights targets related to PI3K/AKT/mTOR signaling and immune response pathways that have been successfully modulated using CRISPR/Cas9.\"}]","Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology - special focus on androgen receptor signaling | PDF",1790010802]